Blog

Powerless study, not the vaccine

Posted on 20 March, 202120 March, 2021Tags , , , ,   Leave a comment on Powerless study, not the vaccine

Now this? The last publication in New England Journal of Medicine  declared that the long-suffering Astra Zeneca vaccine was inefficient against the South African variant B.1.351. More specifically, the numbers of those who developed mild-to-moderate Covid-19 were 23 of 717 placebo recipients (3.2%) and 19 of 750 vaccine recipients (2.5%). Out of these 42 individuals, 39 contracted just B.1.351, so that the results should convey loss of efficacy against the new variant. However, the study demonstrated a different thing instead: … Continue reading “Powerless study, not the vaccine”

Russel’s teapot, or would serology suitable for historical reconstructions of COVID-19?

Posted on 8 December, 202018 January, 2021Tags , ,   Leave a comment on Russel’s teapot, or would serology suitable for historical reconstructions of COVID-19?

“SARS–CoV–2 was circulating outside of China back in 2019”. Sounds familiar? One of most recent claims of this sort came about three weeks ago from Italy. A joined team of Istituto Nazionale Tumori (Milan), University of Siena, and a company VisMederi Srl re-analyzed blood samples spared from a cancer related project with around 1000 participants. Apolone and co-authors reported that up to 15% of the samples might had contained antibodies to the receptor-binding domain (RBD) of SARS-CoV-2 already by September … Continue reading “Russel’s teapot, or would serology suitable for historical reconstructions of COVID-19?”